A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 340 participants.

Also called NCT02916602

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 340 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02916602
Other papers using this trial's data
  • Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study Clinical therapeutics, 2017-10 DOI, PubMed 28939406

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02916602. Randomized; double masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2016-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
Condition
Hypertension
Intervention (Drug)
HCP1401
Intervention (Drug)
HCP0605
Lead sponsor
Hanmi Pharmaceutical Company Limited (class: industry)

Record details

Record id
cardio:ct-nct02916602
Content hash
8aeaf5ed062aba1fc7b30f2f9f935fd32074c05d38004959f50941587cc1a973